Patient Pathfinder: Clinical Trials
Clinical Trials for AL Amyloidosis
There are 21 active AL Amyloidosis trials
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
Study Type: Interventional Phase 1
Amyloidosis Incidence in High-Risk Cardiac Device Patients
Study Type: Observational
Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis
Study Type: Interventional Phase 1
Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders
Study Type: Observational
Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
Study Type: Interventional Phase 1
Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE)
Study Type: Interventional Phase 1
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Study Type: Interventional Phase 2
Ixazomib Maintenance Study in Patients With AL Amyloidosis
Study Type: Interventional Phase 2
There are 21 active AL Amyloidosis trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now